REQUEST A DEMO
Total
USD $0.00
Search more companies

Bioplus Co., Ltd. (South Korea)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Full name: Bioplus Co., Ltd. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The company is a Korea-based company principally engaged in the medical device business. The Company is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products. The Company was established on May 23, 2003. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on September 27, 2021.

Headquarters
Seongnam Woolim Lions Valley 2 Cha A Dong 1801 And 1802 Ho, Sagimakgol-Ro 45Th Street 14, Jungwon-Gu
Seongnam; Gyeonggi;

Contact Details: Purchase the Bioplus Co., Ltd. report to view the information.

Website: http://bioplus.co.kr

Basic Information
Total Employees:
Purchase the Bioplus Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Bioplus Co., Ltd. report to view the information.
Registered Capital:
Purchase the Bioplus Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Bioplus Co., Ltd. report to view the information.
Incorporation Date:
June 01, 2003
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
바이오플러스(주)
Company Performance
Financial values in the chart are available after Bioplus Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
14.68%
Total operating revenue
16.46%
Operating profit (EBIT)
19.78%
EBITDA
16.08%
Net Profit (Loss) for the Period
32.42%
Total assets
17.94%
Total equity
20.09%
Operating Profit Margin (ROS)
1.9%
Net Profit Margin
5.65%
Return on Equity (ROE)
1.85%
Debt to Equity Ratio
1.06%
Quick Ratio
-2.11%
Cash Ratio
2.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?